ClassID:

94689

C07D265/06 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms 1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings

Sub-classes:
Recent Application in this class:
#1
20240132440
2024-04-25

METHOD FOR THE PRODUCTION OF D-ERYTHRO-SPHINGOSINE AND ANALOGS THEREOF

#2
20240092830
2024-03-21

PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE

#3
20220002257
2022-01-06

Production method for hemiaminal compound and production method for heterocyclic compound

#4
20210147400
2021-05-20

Method for producing (2S)-2-[(1H-pyrazol-1-yl)methyl]-1,3-oxazinane derivative

#5
20160176828
2016-06-23

Antimicrobial compounds

#6
20160159757
2016-06-09

Oxazine derivatives

#7
20160024044
2016-01-28

Inhibiting neurotransmitter reuptake

#8
20150166491
2015-06-18

Oxazine derivatives

#9
20150057269
2015-02-26

Compositions and methods for the modulation of specific amidases for N-acylethanolamines for use in the therapy of inflammatory diseases

#10
20140235629
2014-08-21

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

#11
20140024837
2014-01-23

Cinnamoyl inhibitors of transglutaminase

#12
20130225596
2013-08-29

Heterocyclic derivative and pharmaceutical composition comprising the same

#13
20130189246
2013-07-25

TREATMENT OF OPHTHALMIC CONDITIONS WITH FLUORENONE DERIVATIVES

#14
20120245157
2012-09-27

Oxazine derivatives

#15
20120034321
2012-02-09

Nitric oxide enhancing prostaglandin compounds, compositions and methods of use

#16
20110294787
2011-12-01

Substituted thiomorpholine derivatives

#17
20110165101
2011-07-07

PHOTO-LABILE PRO-FRAGRANCE CONJUGATES

#18
20110046237
2011-02-24

Compounds with activity at estrogen receptors

#19
20110028367
2011-02-03

PHOTO-LABILE PRO-FRAGRANCE CONJUGATES

#20
20100272656
2010-10-28

Flavor molecules

#21
20100240622
2010-09-23

Nitric oxide enhancing prostaglandin compounds, compositions and methods of use

#22
20100210495
2010-08-19

PHOTO-LABILE PRO-FRAGRANCE CONJUGATES

#23
20100204280
2010-08-12

Cinnamoyl inhibitors of transglutaminase

#24
20100063036
2010-03-11

Substituted thiomorpholine derivatives

#25
20100063033
2010-03-11

Methods of using substituted morpholine derivatives

#26
20100048947
2010-02-25

PURIFICATION METHOD OF 4-HYDROXYISOLEUCINE

#27
20100040569
2010-02-18

PHOTO-LABILE PRO-FRAGRANCE CONJUGATES

#28
20090187017
2009-07-23

PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED BETA-AMINO ACID DERIVATIVES

#29
20090186790
2009-07-23

PHOTO-LABILE PRO-FRAGRANCE CONJUGATES

#30
20090176944
2009-07-09

Aldimines Comprising Reactive Groups Containing Active Hydrogen, and Use Thereof

#31
20090143369
2009-06-04

METHODS OF USING SUBSTITUTED MORPHOLINE AND THIOMORPHOLINE DERIVATIVES

#32
20090137571
2009-05-28

Substituted morpholine and thiomorpholine derivatives

#33
20090048240
2009-02-19

Antibacterial agents

#34
20080171681
2008-07-17

Photo-labile pro-fragrance conjugates

#35
20080027211
2008-01-31

Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments

#36
20070264217
2007-11-15

Photo-labile pro-fragrance conjugates

#37
20070117740
2007-05-24

Photo-labile pro-fragrance conjugates

#38
20060252093
2006-11-09

Heterocyclic organic molecules through intramolecular formation of n-acyliminium ions

#39
20060223726
2006-10-05

Photo-labile pro-fragrance conjugates

#40
20060199853
2006-09-07

Analogs of 4-hydroxyisoleucine and uses thereof

#41
20060167248
2006-07-27

Substituted morpholine and thiomorpholine derivatives

#42
20060122278
2006-06-08

Compounds with activity at estrogen receptors

#43
20060084688
2006-04-20

Aromatic sulfone hydroxamic acid metalloprotease inhibitor

#44
20060074072
2006-04-06

Carboxamide derivatives and their use as factor Xa inhibitors

#45
20050245408
2005-11-03

Photo-labile pro-fragrance conjugates

#46
20050224756
2005-10-13

3,3,4,4-Tetrafluorocyclopentane compounds, used as components of liquid crystal media